PureTech Health (PRTC) Price & Analysis

Compare

20 Followers

PRTC Stock Chart & Stats

Day’s Range― - ―

52-Week Range100.40p - 178.00p

Previous CloseN/A

Volume88.39K

Average Volume (3M)1.05M

Market Cap

£302.11M

Enterprise Value74.66M

Total Cash (Recent Filing)£367.31M

Total Debt (Recent Filing)£22.36M

Price to Earnings (P/E)8.8

Beta1.98

Next Earnings

Apr 23, 2026

EPS Estimate

-0.14

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.14

Shares Outstanding241,684,040

10 Day Avg. Volume1,922,658

30 Day Avg. Volume1,054,881

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

£130.00

Price Target Upside4.00% Upside

Rating ConsensusHold

Number of Analyst Covering0

PureTech Health News

PureTech Health says Seaport Therapeutics doses first patient in GlyphAgo study

PureTech Health (PRTC) noted that its founded entity, Seaport Therapeutics, announced that the first participant has been dosed...

17d ago

PRTC

PureTech Health Executives Increase Shareholdings, Indicating Confidence in Future Prospects

PureTech Health ( ($GB:PRTC) ) has shared an announcement. PureTech Health announced that key members of its management...

4d ago

Seaport Therapeutics Advances GlyphAgo for Generalized Anxiety Disorder

PureTech Health ( ($GB:PRTC) ) just unveiled an announcement. Seaport Therapeutics has initiated a Phase 1 clinical trial...

17d ago

Buy Rating for PureTech Health Driven by Promising LYT-100 Developments and Strategic Initiatives

Faisal Khurshid, an analyst from Leerink Partners, reiterated the Buy rating on PureTech Health. The associated price target...

27d ago

PRTC

PureTech Health Discloses August 2025 Share Capital and Voting Rights

PureTech Health ( ($GB:PRTC) ) has provided an announcement. PureTech Health announced its total voting rights and share...

27d ago

PureTech Health’s Earnings Call: Cautious Optimism Amidst Changes

PureTech Health (($GB:PRTC)) has held its Q2 earnings call. Read on for the main highlights of the call....

28d ago

PureTech Health Advances Portfolio with Strong Financial Position

PureTech Health ( ($GB:PRTC) ) has issued an update. PureTech Health has reported significant progress in its diversified...

1M ago

PureTech Health Advances Deupirfenidone in IPF Treatment

PureTech Health ( ($GB:PRTC) ) just unveiled an update. PureTech Health has showcased its development strategy at the...

1M ago

PureTech Health to Announce Half-Yearly Financial Results

An announcement from PureTech Health ( ($GB:PRTC) ) is now available. PureTech Health announced that it will release...

1M ago

PureTech says Vedanta ulcerative colitis study missed endpoint

PureTech Health (PRTC), noted that its Founded Entity, Vedanta Biosciences, announced that its candidate VE202 did not meet...

2M ago

PRTC

PureTech falls 7% to $16.19 after founded entity study miss

12:18 EDT PureTech falls 7% to $16.19 after founded entity study miss Published first on TheFly – the...

2M ago

PRTC

Vedanta Biosciences Shifts Focus After VE202 Study Misses Endpoint

The latest announcement is out from PureTech Health ( ($GB:PRTC) ). Vedanta Biosciences, a PureTech Founded Entity, announced...

2M ago

PureTech Health Launches Celea Therapeutics to Revolutionize Respiratory Disease Treatment

An update from PureTech Health ( ($GB:PRTC) ) is now available. PureTech Health has launched Celea Therapeutics, a...

2M ago

DiaMedica Therapeutics CMO Lorianne Masuoka resigns, Julie Krop succeeds

DiaMedica Therapeutics (DMAC) announced the appointment of Julie Krop as chief medical officer, effective immediately. Krop will succeed...

2M ago

DMAC

PRTC

PRTC FAQ

What was PureTech Health PLC’s price range in the past 12 months?

PureTech Health PLC lowest share price was 100.40p and its highest was 178.00p in the past 12 months.

What is PureTech Health PLC’s market cap?

PureTech Health PLC’s market cap is £302.11M.

When is PureTech Health PLC’s upcoming earnings report date?

PureTech Health PLC’s upcoming earnings report date is Apr 23, 2026 which is in 207 days.

How were PureTech Health PLC’s earnings last quarter?

PureTech Health PLC released its earnings results on Aug 28, 2025. The company reported -0.141p earnings per share for the quarter, beating the consensus estimate of -0.151p by 0.01p.

Is PureTech Health PLC overvalued?

According to Wall Street analysts PureTech Health PLC’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does PureTech Health PLC pay dividends?

PureTech Health PLC does not currently pay dividends.

What is PureTech Health PLC’s EPS estimate?

PureTech Health PLC’s EPS estimate is -0.14.

How many shares outstanding does PureTech Health PLC have?

PureTech Health PLC has 241,684,040 shares outstanding.

What happened to PureTech Health PLC’s price movement after its last earnings report?

PureTech Health PLC reported an EPS of -0.141p in its last earnings report, beating expectations of -0.151p. Following the earnings report the stock price went down -5.522%.

Which hedge fund is a major shareholder of PureTech Health PLC?

Currently, no hedge funds are holding shares in GB:PRTC

PureTech Health Stock Smart Score

Neutral

Fundamentals

Return on Equity

15.04%

Trailing 12-Months

Asset Growth

-12.00%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

PureTech Health PLC

PureTech Health (PRTC) is an innovative biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies for patients with serious diseases. The company operates in various sectors, including neurology, immunology, and gastrointestinal disorders, leveraging its proprietary platform technologies to create a pipeline of novel therapeutics. Core products and services include drug development programs and strategic partnerships aimed at advancing its candidate therapies through clinical trials.